BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1623486)

  • 41. Brief chemotherapy, Stanford V, and adjuvant radiotherapy for bulky or advanced-stage Hodgkin's disease: a preliminary report.
    Bartlett NL; Rosenberg SA; Hoppe RT; Hancock SL; Horning SJ
    J Clin Oncol; 1995 May; 13(5):1080-8. PubMed ID: 7537796
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Stage I-III Hodgkin's disease: outcome and pattern of failure following treatment with radiation therapy and chemotherapy in a modern era.
    Zapatero A; López MA; Cerezo L; De Vidales CM; MarIn A; Pérez-Torrubia A
    Hematology; 2002 Feb; 7(1):43-50. PubMed ID: 12171776
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Analysis of prognostic factors after the first relapse of Hodgkin's disease in 187 patients.
    Brice P; Bastion Y; Divine M; Nedellec G; Ferrant A; Gabarre J; Reman O; Lepage E; Fermé C
    Cancer; 1996 Sep; 78(6):1293-9. PubMed ID: 8826953
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Alternating MOPP and ABVD chemotherapy plus mantle-field radiation therapy in patients with massive mediastinal Hodgkin's disease.
    Longo DL; Glatstein E; Duffey PL; Young RC; Ihde DC; Bastian AW; Wilson WH; Wittes RE; Jaffe ES; Hubbard SM; DeVita VT
    J Clin Oncol; 1997 Nov; 15(11):3338-46. PubMed ID: 9363863
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Twenty-year disease and treatment-associated mortality rates of patients with Hodgkin lymphoma of clinical stages IIIB and IV prospectively treated with 3-month anthracycline-based chemotherapy followed by extended high-dose radiation.
    Sénécal D; Jais JP; Desablens B; Berthou C; Casassus P; Moles MP; Delwail V; Gastinne T; Colonna P; Andrieu JM
    Cancer; 2008 Feb; 112(4):846-55. PubMed ID: 18072259
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Is intensity-modulated radiotherapy better than conventional radiation treatment and three-dimensional conformal radiotherapy for mediastinal masses in patients with Hodgkin's disease, and is there a role for beam orientation optimization and dose constraints assigned to virtual volumes?
    Girinsky T; Pichenot C; Beaudre A; Ghalibafian M; Lefkopoulos D
    Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):218-26. PubMed ID: 16169675
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hodgkin's disease: a reassessment of prognostic factors following modification of radiotherapy.
    Lee CK; Aeppli DM; Bloomfield CD; Levitt SH
    Int J Radiat Oncol Biol Phys; 1987 Jul; 13(7):983-91. PubMed ID: 3597162
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Individualized estimates of second cancer risks after contemporary radiation therapy for Hodgkin lymphoma.
    Hodgson DC; Koh ES; Tran TH; Heydarian M; Tsang R; Pintilie M; Xu T; Huang L; Sachs RK; Brenner DJ
    Cancer; 2007 Dec; 110(11):2576-86. PubMed ID: 17941006
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Stage I and II Hodgkin's disease with enlarged mediastinum in adults. Apropos of 24 cases].
    Touboul E; Beral HM; Grigoraki V; Raphael M; Taelman P; Chantelard JV; Gabarre J; Bro S; Guerin RA
    Rev Mal Respir; 1988; 5(6):619-27. PubMed ID: 3146115
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Heart and coronary artery protection in patients with mediastinal Hodgkin lymphoma treated with intensity-modulated radiotherapy: dose constraints to virtual volumes or to organs at risk?
    Ghalibafian M; Beaudre A; Girinsky T
    Radiother Oncol; 2008 Apr; 87(1):82-8. PubMed ID: 18037182
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mediastinal involvement by Hodgkin's disease and the implications for management for those patients with local or loco-regional disease.
    Sutcliffe SB; Gospodarowicz M; Bush RS
    Hematol Oncol; 1984; 2(1):74-6. PubMed ID: 6735351
    [No Abstract]   [Full Text] [Related]  

  • 52. Analyses of patterns-of-failure and prognostic factors according to radiation fields in early-stage Hodgkin lymphoma.
    Krebs L; Amorin S; Brice P; Guillerm S; Menard J; Hennequin C; Quéro L
    Strahlenther Onkol; 2017 Feb; 193(2):116-124. PubMed ID: 27316376
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Randomized comparison of low-dose involved-field radiotherapy and no radiotherapy for children with Hodgkin's disease who achieve a complete response to chemotherapy.
    Nachman JB; Sposto R; Herzog P; Gilchrist GS; Wolden SL; Thomson J; Kadin ME; Pattengale P; Davis PC; Hutchinson RJ; White K;
    J Clin Oncol; 2002 Sep; 20(18):3765-71. PubMed ID: 12228196
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Radiotherapy in early stage classical Hodgkin lymphoma: past, present and future.
    Zhang W
    Chin Clin Oncol; 2015 Mar; 4(1):6. PubMed ID: 25841713
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Second malignant tumours in childhood Hodgkin's disease.
    Jenkin D; Greenberg M; Fitzgerald A
    Med Pediatr Oncol; 1996 Jun; 26(6):373-9. PubMed ID: 8614372
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Stage I Hodgkin disease: radiation therapy and chemotherapy at the University of Texas M. D. Anderson Cancer Center, 1996-1997.
    Vlachaki MT; Ha CS; Hagemeister FB; Fuller LM; Rodriguez MA; Hess MA; Tucker SL; Cabanillas F; Cox JD
    Radiology; 1998 Sep; 208(3):739-47. PubMed ID: 9722855
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Extended-field radiotherapy is superior to MOPP chemotherapy for the treatment of pathologic stage I-IIA Hodgkin's disease: eight-year update of an Italian prospective randomized study.
    Biti GP; Cimino G; Cartoni C; Magrini SM; Anselmo AP; Enrici RM; Bellesi GP; Bosi A; Papa G; Giannarelli D
    J Clin Oncol; 1992 Mar; 10(3):378-82. PubMed ID: 1740677
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Does Radiation Have a Role in Advanced Stage Hodgkin's or Non-Hodgkin Lymphoma?
    Specht L
    Curr Treat Options Oncol; 2016 Jan; 17(1):4. PubMed ID: 26739151
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Combination chemotherapy plus low-dose involved-field radiotherapy for early clinical stage Hodgkin's lymphoma.
    Vassilakopoulos TP; Angelopoulou MK; Siakantaris MP; Kontopidou FN; Dimopoulou MN; Kokoris SI; Kyrtsonis MC; Tsaftaridis P; Karkantaris C; Anargyrou K; Boutsis DE; Variamis E; Michalopoulos T; Boussiotis VA; Panayiotidis P; Papavassiliou C; Pangalis GA
    Int J Radiat Oncol Biol Phys; 2004 Jul; 59(3):765-81. PubMed ID: 15183480
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Ten-year results of a strategy combining three cycles of ABVD and high-dose extended irradiation for treating Hodgkin's disease at advanced stages.
    Andrieu JM; Jais JP; Colonna P; Desablens B; Brière J; François S; Harousseau JL; Casassus P; Lemevel A; Le Prisé PY; Ghandour C; Guilhot F; Lejeune F
    Ann Oncol; 1998 Feb; 9(2):195-203. PubMed ID: 9553666
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.